Skip to main content
logo
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.130
+0.010 (0.89%)
At close: Sep 1, 2026, 4:00 PM EDT
1.142
+0.012 (1.09%)
After-hours: Sep 1, 2026, 7:21 PM EDT

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $9.26M in the quarter ending June 30, 2026, a decrease of -1.56%. This brings the company's revenue in the last twelve months to $35.35M, down -21.87% year-over-year. In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth.

Revenue (ttm)
$35.35M
Revenue Growth
-21.87%
P/S Ratio
0.12
Revenue / Employee
$706,935
Employees
50
Market Cap
4.38M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.31M1.43M4.11%
Dec 31, 202434.87M10.78M44.75%
Dec 31, 202324.09M19.75M454.42%
Dec 31, 20224.35M4.12M1,802.41%
Dec 31, 2021228.43K157.02K219.88%
Dec 31, 202071.41K50.29K238.10%
Dec 31, 201921.12K--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 20151.71K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Jul 31, 2009---
Jul 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Sonoma Pharmaceuticals21.92M
cbdMD20.93M
Universe Pharmaceuticals INC17.74M
InMed Pharmaceuticals4.94M
BioXcel Therapeutics742.00K
Gelteq314.70K
RedHill Biopharma286.00K
Akanda258.08K
Revenue Rankings

SBFM News

More News